Recursion Pharmaceuticals, Inc. (RXRX) earnings

Earnings (net income) · fiscal 2025
-$644.76M

Recursion Pharmaceuticals, Inc. (RXRX) reported net income of -$644.76M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$463.66M. Figures as of 18 Nov 2026, 08:22 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
-$644.76M
Highest on record
-$61.88Mfiscal 2019
Lowest on record
-$644.76Mfiscal 2025
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Recursion Pharmaceuticals, Inc. earnings, in more detail

Across the 7 fiscal years on record (2019–2025), the highest was -$61.88M in fiscal 2019 and the lowest -$644.76M in fiscal 2025.

History · 7 fiscal years

Earnings (net income) by fiscal year

Recursion Pharmaceuticals, Inc. earnings, year by year

Recursion Pharmaceuticals, Inc. (RXRX) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025-$644.76M—
2024-$463.66M—
2023-$328.07M—
2022-$239.48M—
2021-$186.48M—
2020-$87.01M—
2019-$61.88M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

More on RXRX

Recursion Pharmaceuticals, Inc., figure by figure

Recursion Pharmaceuticals, Inc. (RXRX) overview: price, valuation and scorecard

Recursion Pharmaceuticals, Inc. earnings: questions and answers

What is Recursion Pharmaceuticals, Inc.'s net income?

Recursion Pharmaceuticals, Inc. (RXRX) reported net income of -$644.76M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$463.66M.

What are the highest and lowest net income figures on record for Recursion Pharmaceuticals, Inc.?

Across the 7 fiscal years on record (2019–2025), the highest was -$61.88M in fiscal 2019 and the lowest -$644.76M in fiscal 2025.

How is Recursion Pharmaceuticals, Inc.'s net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Recursion Pharmaceuticals, Inc. (RXRX) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/RXRX/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.